nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethizole—ALB—epilepsy syndrome	0.279	1	CbGaD
Sulfamethizole—ALB—Oxcarbazepine—epilepsy syndrome	0.0891	0.128	CbGbCtD
Sulfamethizole—ALB—Fosphenytoin—epilepsy syndrome	0.0778	0.112	CbGbCtD
Sulfamethizole—ALB—Clonazepam—epilepsy syndrome	0.0704	0.101	CbGbCtD
Sulfamethizole—ALB—Rufinamide—epilepsy syndrome	0.0574	0.0824	CbGbCtD
Sulfamethizole—ALB—Phenytoin—epilepsy syndrome	0.0502	0.0721	CbGbCtD
Sulfamethizole—ALB—Propofol—epilepsy syndrome	0.0468	0.0672	CbGbCtD
Sulfamethizole—CYP2C9—Trimethadione—epilepsy syndrome	0.0446	0.0641	CbGbCtD
Sulfamethizole—ALB—Diazepam—epilepsy syndrome	0.0424	0.0609	CbGbCtD
Sulfamethizole—CYP2C9—Fosphenytoin—epilepsy syndrome	0.042	0.0603	CbGbCtD
Sulfamethizole—CYP2C9—Carbamazepine—epilepsy syndrome	0.0301	0.0433	CbGbCtD
Sulfamethizole—CYP2C9—Primidone—epilepsy syndrome	0.0281	0.0404	CbGbCtD
Sulfamethizole—CYP2C9—Phenytoin—epilepsy syndrome	0.027	0.0388	CbGbCtD
Sulfamethizole—CYP2C9—Propofol—epilepsy syndrome	0.0252	0.0362	CbGbCtD
Sulfamethizole—CYP2C9—Phenobarbital—epilepsy syndrome	0.0241	0.0346	CbGbCtD
Sulfamethizole—CYP2C9—Diazepam—epilepsy syndrome	0.0228	0.0328	CbGbCtD
Sulfamethizole—CYP2C9—Valproic Acid—epilepsy syndrome	0.018	0.0259	CbGbCtD
Sulfamethizole—Sulfamethazine—ALB—epilepsy syndrome	0.000262	0.192	CrCbGaD
Sulfamethizole—Sulfamerazine—ALB—epilepsy syndrome	0.000256	0.187	CrCbGaD
Sulfamethizole—Sulfanilamide—CYP2C19—epilepsy syndrome	0.000176	0.129	CrCbGaD
Sulfamethizole—Sulfaphenazole—CYP2D6—epilepsy syndrome	0.000176	0.129	CrCbGaD
Sulfamethizole—Dapsone—CYP2C19—epilepsy syndrome	0.000157	0.115	CrCbGaD
Sulfamethizole—Sulfanilamide—CYP2D6—epilepsy syndrome	0.00013	0.0955	CrCbGaD
Sulfamethizole—Sulfamethoxazole—ALB—epilepsy syndrome	0.000111	0.0815	CrCbGaD
Sulfamethizole—Dapsone—PTGS2—epilepsy syndrome	9.77e-05	0.0716	CrCbGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	7.15e-05	0.00299	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—FLNA—epilepsy syndrome	7.12e-05	0.00298	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—CCL2—epilepsy syndrome	7.11e-05	0.00298	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—CAT—epilepsy syndrome	7.04e-05	0.00294	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—CRP—epilepsy syndrome	7.03e-05	0.00294	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	6.92e-05	0.0029	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	6.92e-05	0.0029	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	6.92e-05	0.0029	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	6.65e-05	0.00278	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—GPX1—epilepsy syndrome	6.36e-05	0.00266	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	6.33e-05	0.00265	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—SLC8A2—epilepsy syndrome	6.06e-05	0.00254	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—RELA—epilepsy syndrome	5.96e-05	0.0025	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	5.96e-05	0.00249	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	5.96e-05	0.00249	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	5.85e-05	0.00245	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—CCL2—epilepsy syndrome	5.78e-05	0.00242	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—SLC8A3—epilepsy syndrome	5.78e-05	0.00242	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	5.65e-05	0.00237	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	5.6e-05	0.00234	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—CRP—epilepsy syndrome	5.59e-05	0.00234	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—COX3—epilepsy syndrome	5.53e-05	0.00232	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.52e-05	0.00231	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—IL1B—epilepsy syndrome	5.39e-05	0.00226	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	5.3e-05	0.00222	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	5.24e-05	0.0022	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	5.24e-05	0.0022	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	5.24e-05	0.0022	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.22e-05	0.00219	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP2C19—epilepsy syndrome	5.12e-05	0.00214	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP11A1—epilepsy syndrome	5.09e-05	0.00213	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	5.05e-05	0.00211	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	5.04e-05	0.00211	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	5.04e-05	0.00211	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.02e-05	0.0021	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	5e-05	0.00209	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	5e-05	0.00209	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.86e-05	0.00203	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—RELA—epilepsy syndrome	4.85e-05	0.00203	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	4.82e-05	0.00202	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—CCL2—epilepsy syndrome	4.59e-05	0.00192	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	4.59e-05	0.00192	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.53e-05	0.00189	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.51e-05	0.00189	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.41e-05	0.00185	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IL1B—epilepsy syndrome	4.39e-05	0.00184	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	4.37e-05	0.00183	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CA13—epilepsy syndrome	4.28e-05	0.00179	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.23e-05	0.00177	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.13e-05	0.00173	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—APOD—epilepsy syndrome	4.08e-05	0.00171	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.97e-05	0.00166	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.97e-05	0.00166	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.97e-05	0.00166	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—TNF—epilepsy syndrome	3.91e-05	0.00164	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—TEK—epilepsy syndrome	3.9e-05	0.00163	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—RELA—epilepsy syndrome	3.85e-05	0.00161	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	3.83e-05	0.0016	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	3.79e-05	0.00159	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	3.75e-05	0.00157	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—FLNA—epilepsy syndrome	3.67e-05	0.00154	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	3.64e-05	0.00153	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	3.64e-05	0.00152	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	3.64e-05	0.00152	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	3.64e-05	0.00152	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	3.64e-05	0.00152	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.61e-05	0.00151	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CA13—epilepsy syndrome	3.5e-05	0.00147	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	3.49e-05	0.00146	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	3.48e-05	0.00146	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—KCNMA1—epilepsy syndrome	3.48e-05	0.00146	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.44e-05	0.00144	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—SLC8A1—epilepsy syndrome	3.44e-05	0.00144	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	3.38e-05	0.00141	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	3.28e-05	0.00137	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ADK—epilepsy syndrome	3.24e-05	0.00136	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PDXK—epilepsy syndrome	3.24e-05	0.00136	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—L2HGDH—epilepsy syndrome	3.24e-05	0.00136	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—FAR1—epilepsy syndrome	3.24e-05	0.00136	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GLUD1—epilepsy syndrome	3.24e-05	0.00136	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CERS1—epilepsy syndrome	3.24e-05	0.00136	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.22e-05	0.00135	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	3.18e-05	0.00133	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—TNF—epilepsy syndrome	3.18e-05	0.00133	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.18e-05	0.00133	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	3.11e-05	0.0013	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.09e-05	0.00129	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	3.03e-05	0.00127	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	2.99e-05	0.00125	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.98e-05	0.00125	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.97e-05	0.00124	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PNPO—epilepsy syndrome	2.96e-05	0.00124	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—EPM2A—epilepsy syndrome	2.96e-05	0.00124	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.96e-05	0.00124	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GAMT—epilepsy syndrome	2.96e-05	0.00124	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PPIA—epilepsy syndrome	2.89e-05	0.00121	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.87e-05	0.0012	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.87e-05	0.0012	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.82e-05	0.00118	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—QDPR—epilepsy syndrome	2.76e-05	0.00115	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CA4—epilepsy syndrome	2.76e-05	0.00115	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.75e-05	0.00115	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CERS1—epilepsy syndrome	2.65e-05	0.00111	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ADK—epilepsy syndrome	2.65e-05	0.00111	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PDXK—epilepsy syndrome	2.65e-05	0.00111	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—FAR1—epilepsy syndrome	2.65e-05	0.00111	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	2.65e-05	0.00111	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	2.65e-05	0.00111	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.64e-05	0.0011	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—COX3—epilepsy syndrome	2.59e-05	0.00108	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.56e-05	0.00107	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ITGA2—epilepsy syndrome	2.56e-05	0.00107	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	2.53e-05	0.00106	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	2.47e-05	0.00103	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CACNA2D2—epilepsy syndrome	2.46e-05	0.00103	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—SLCO1A2—epilepsy syndrome	2.46e-05	0.00103	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—KCNB1—epilepsy syndrome	2.46e-05	0.00103	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PFKL—epilepsy syndrome	2.46e-05	0.00103	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—SLC6A8—epilepsy syndrome	2.46e-05	0.00103	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	2.43e-05	0.00102	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	2.43e-05	0.00102	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PNPO—epilepsy syndrome	2.43e-05	0.00102	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GAMT—epilepsy syndrome	2.43e-05	0.00102	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.4e-05	0.001	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.39e-05	0.000999	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.34e-05	0.00098	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.28e-05	0.000956	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CA4—epilepsy syndrome	2.26e-05	0.000944	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—QDPR—epilepsy syndrome	2.26e-05	0.000944	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ADRA2A—epilepsy syndrome	2.25e-05	0.000942	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	2.25e-05	0.000941	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—NEU1—epilepsy syndrome	2.25e-05	0.00094	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ATIC—epilepsy syndrome	2.25e-05	0.00094	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—UPB1—epilepsy syndrome	2.25e-05	0.00094	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PLAT—epilepsy syndrome	2.24e-05	0.000939	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—HSD17B4—epilepsy syndrome	2.16e-05	0.000905	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—COX3—epilepsy syndrome	2.12e-05	0.000888	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—NOS1—epilepsy syndrome	2.11e-05	0.000882	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GBE1—epilepsy syndrome	2.09e-05	0.000874	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PPP1R3C—epilepsy syndrome	2.09e-05	0.000874	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.04e-05	0.000854	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	2.01e-05	0.000842	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	2.01e-05	0.000842	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PFKL—epilepsy syndrome	2.01e-05	0.000842	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	2.01e-05	0.000842	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	2.01e-05	0.000842	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—AKT3—epilepsy syndrome	1.97e-05	0.000826	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.97e-05	0.000823	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ASAH1—epilepsy syndrome	1.96e-05	0.000822	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.95e-05	0.000817	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.95e-05	0.000816	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.94e-05	0.000812	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—STXBP1—epilepsy syndrome	1.91e-05	0.0008	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—NT5E—epilepsy syndrome	1.86e-05	0.000779	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ALAD—epilepsy syndrome	1.86e-05	0.000779	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.85e-05	0.000775	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.84e-05	0.00077	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.84e-05	0.00077	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.84e-05	0.00077	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—CDC42—epilepsy syndrome	1.8e-05	0.000754	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.78e-05	0.000743	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.78e-05	0.000743	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.77e-05	0.000741	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.74e-05	0.000727	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.71e-05	0.000716	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.71e-05	0.000716	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ADSL—epilepsy syndrome	1.7e-05	0.000713	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.67e-05	0.000699	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GLUL—epilepsy syndrome	1.67e-05	0.000699	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.64e-05	0.000686	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.61e-05	0.000673	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—FYN—epilepsy syndrome	1.6e-05	0.000671	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.56e-05	0.000654	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.54e-05	0.000645	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.53e-05	0.000642	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.52e-05	0.000638	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.52e-05	0.000638	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.52e-05	0.000638	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.51e-05	0.000632	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—AQP1—epilepsy syndrome	1.49e-05	0.000623	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.46e-05	0.000612	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.45e-05	0.000608	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.45e-05	0.000608	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.45e-05	0.000607	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.43e-05	0.000598	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.42e-05	0.000595	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.41e-05	0.000591	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.39e-05	0.000583	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PLAU—epilepsy syndrome	1.37e-05	0.000573	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.37e-05	0.000572	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.35e-05	0.000563	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CHRM3—epilepsy syndrome	1.35e-05	0.000563	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.34e-05	0.000562	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.27e-05	0.000532	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—NOS2—epilepsy syndrome	1.26e-05	0.000526	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.25e-05	0.000525	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.25e-05	0.000525	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.23e-05	0.000514	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.22e-05	0.00051	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.17e-05	0.00049	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.1e-05	0.000461	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.1e-05	0.000461	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ABCG2—epilepsy syndrome	1.1e-05	0.000459	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.07e-05	0.000448	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.06e-05	0.000445	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.05e-05	0.000442	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.03e-05	0.000429	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.01e-05	0.000421	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP2D6—epilepsy syndrome	9.59e-06	0.000401	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ADRA2A—epilepsy syndrome	9.13e-06	0.000382	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—BCHE—epilepsy syndrome	9.09e-06	0.000381	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	9.01e-06	0.000377	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	8.98e-06	0.000376	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	8.75e-06	0.000366	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	8.7e-06	0.000364	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—SLC2A1—epilepsy syndrome	8.67e-06	0.000363	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.63e-06	0.000361	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PLCB1—epilepsy syndrome	8.58e-06	0.000359	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—TH—epilepsy syndrome	8.55e-06	0.000358	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.41e-06	0.000352	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.87e-06	0.00033	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	7.85e-06	0.000329	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—SRC—epilepsy syndrome	7.47e-06	0.000313	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	7.47e-06	0.000313	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—BCHE—epilepsy syndrome	7.44e-06	0.000311	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—VEGFA—epilepsy syndrome	7.28e-06	0.000305	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—HMOX1—epilepsy syndrome	7.13e-06	0.000299	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	7.1e-06	0.000297	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CAT—epilepsy syndrome	7.04e-06	0.000295	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	7.02e-06	0.000294	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—TH—epilepsy syndrome	7e-06	0.000293	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.89e-06	0.000288	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ABCB1—epilepsy syndrome	6.85e-06	0.000287	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GPX1—epilepsy syndrome	6.37e-06	0.000266	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	5.84e-06	0.000244	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CAT—epilepsy syndrome	5.76e-06	0.000241	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	5.6e-06	0.000235	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—AGT—epilepsy syndrome	5.58e-06	0.000234	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—APOE—epilepsy syndrome	5.47e-06	0.000229	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GPX1—epilepsy syndrome	5.21e-06	0.000218	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—POMC—epilepsy syndrome	4.7e-06	0.000197	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—AKT1—epilepsy syndrome	4.65e-06	0.000194	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—AGT—epilepsy syndrome	4.57e-06	0.000191	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—APOE—epilepsy syndrome	4.48e-06	0.000187	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—POMC—epilepsy syndrome	3.85e-06	0.000161	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PTGS2—epilepsy syndrome	3.75e-06	0.000157	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ALB—epilepsy syndrome	3.51e-06	0.000147	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.07e-06	0.000128	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—AKT1—epilepsy syndrome	1.88e-06	7.88e-05	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.54e-06	6.45e-05	CbGpPWpGaD
